|
Market Closed -
Nasdaq
21:00:00 24/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 828.50 USD | -0.66% |
|
+3.11% | +7.34% |
| 08-19 | Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition | MT |
| 08-19 | US FDA approves Regeneron's rare bone disorder drug | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.66% | +3.11% | +27.09% | +29.68% | +7.34% | +40.55% | -1.46% | +24.16% | +96.98% | 83.28B | |
| -4.30% | +119.35% | +143.58% | +196.27% | +370.97% | +412.13% | +20.29% | -66.28% | - | 57.94B | |
| +0.48% | +23.89% | +46.10% | +69.52% | -2.05% | -21.93% | -35.75% | -44.85% | +53.58% | 57.77B | |
| +1.42% | +1.61% | +14.07% | +11.17% | -7.20% | -0.67% | +34.08% | +1.39% | - | 51.75B | |
| -0.77% | +3.63% | -9.47% | -9.09% | -7.80% | +11.51% | +167.84% | +121.42% | +201.37% | 49.35B | |
| +0.62% | +3.95% | +8.72% | +12.57% | +23.94% | +56.57% | -17.63% | -37.04% | -31.45% | 32.03B | |
| +0.13% | +6.51% | +9.68% | +31.72% | +29.57% | +50.49% | +97.96% | +69.44% | +56.26% | 25.91B | |
| -2.83% | +6.08% | +9.28% | +22.92% | +30.49% | +0.05% | +223.58% | +56.94% | - | 22.74B | |
| -1.74% | +2.63% | -1.40% | +2.40% | +35.82% | +55.54% | +107.34% | +152.51% | +346.64% | 16.87B | |
| +0.16% | +2.07% | +35.94% | +14.31% | -7.31% | -1.27% | +797.95% | +577.48% | +6,611.14% | 16.08B | |
| -0.53% | +1.52% | -2.24% | +17.29% | +5.99% | +65.18% | +183.56% | +64.51% | - | 15.93B | |
| -2.44% | -3.40% | +10.53% | +20.30% | +9.49% | +11.08% | -28.55% | -13.78% | -34.56% | 12.91B | |
| -1.14% | -3.87% | -14.96% | -12.96% | +12.46% | +73.32% | +171.98% | +728.56% | +2,635.02% | 10.88B | |
| -1.40% | +2.84% | +4.34% | +14.12% | +38.61% | +127.08% | +169.75% | +506.85% | - | 10.26B | |
| -3.29% | +18.75% | +52.32% | +132.46% | +343.88% | +392.48% | +592.57% | +30.26% | - | 9.13B | |
| -0.32% | +0.20% | +5.08% | +4.35% | -7.66% | -20.29% | -25.15% | -52.86% | -49.19% | 6.97B | |
| -8.81% | -10.23% | -2.53% | +1.95% | +5.76% | +17.98% | +242.03% | +228.14% | - | 6.35B | |
| +0.44% | +3.43% | +25.90% | +49.10% | +92.44% | +135.20% | +340.02% | +532.51% | - | 6.17B | |
| -4.33% | -12.68% | -1.77% | +21.02% | -3.82% | -4.49% | +58.91% | -12.72% | - | 6.06B | |
| -8.17% | -6.68% | -3.93% | -23.36% | -37.49% | -53.20% | -49.00% | -74.98% | - | 5.75B | |
| Average | -1.41% | +10.05% | +17.82% | +30.29% | +46.67% | +67.37% | +152.52% | +139.58% | +988.58% | 25.21B | |
| Weighted average by Cap. | -0.47% | +20.46% | +30.55% | +43.83% | +55.83% | +75.18% | +90.94% | +66.49% | +517.83% |
- Stock Market
- Stocks
- REGN Stock
- Sector Regeneron Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
